Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| GENOCEA BIOSCIENCES, INC. | 304,377 | reported | 02 Jun 2022 | tx 36+4,709,650−233,805 |
| Vanda Pharmaceuticals Inc. | 168,279 | reported | 19 Feb 2010 | tx 109+1,065,550−672,821 |
| DELTEK, INC | 94,163 | reported | 24 Feb 2010 | tx 13+142,662−103,201 |
| Aldeyra Therapeutics, Inc. | 76,760 | reported | 17 Apr 2025 | tx 1+76,760 |
| iBio, Inc. | 13,500 | reported | 20 Nov 2025 | tx 5+243,238 |
| X4 Pharmaceuticals, Inc | 10,000 | reported | 05 Jun 2018 | tx 3+42,324 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Nov 2025 | GRANT_AWARD | iBio, Inc. | 13,500 | 0.00 USD | deriv |
| 17 Apr 2025 | GRANT_AWARD | Aldeyra Therapeutics, Inc. | 76,760 | 0.00 USD | deriv |
| 10 Jan 2025 | PURCHASE | iBio, Inc. | 1,838 | 2.72 USD | first after silence |
| 21 Nov 2024 | GRANT_AWARD | iBio, Inc. | 18,900 | 0.00 USD | deriv |
| 02 Jun 2022 | SALE | GENOCEA BIOSCIENCES, INC. | 4,023 | 0.06 USD | |
| 31 May 2022 | SALE | GENOCEA BIOSCIENCES, INC. | 117,244 | 0.06 USD | |
| 04 Apr 2022 | SALE | GENOCEA BIOSCIENCES, INC. | 3,924 | 1.25 USD | |
| 15 Mar 2022 | GRANT_AWARD | GENOCEA BIOSCIENCES, INC. | 150,000 | 0.00 USD | |
| 16 Mar 2022 | SALE | GENOCEA BIOSCIENCES, INC. | 11,435 | 1.10 USD | |
| 15 Mar 2022 | GRANT_AWARD | GENOCEA BIOSCIENCES, INC. | 450,000 | 0.00 USD | deriv |
| 02 Apr 2021 | SALE | GENOCEA BIOSCIENCES, INC. | 3,794 | 2.71 USD | |
| 01 Jun 2021 | SALE | GENOCEA BIOSCIENCES, INC. | 2,080 | 2.23 USD | |
| 09 Dec 2021 | GRANT_AWARD | iBio, Inc. | 109,000 | 0.00 USD | deriv |
| 23 Aug 2021 | GRANT_AWARD | iBio, Inc. | 100,000 | 0.00 USD | deriv |
| 15 Mar 2021 | GRANT_AWARD | GENOCEA BIOSCIENCES, INC. | 150,000 | 0.00 USD | |
| 15 Mar 2021 | GRANT_AWARD | GENOCEA BIOSCIENCES, INC. | 450,000 | 0.00 USD | deriv |
| 15 Mar 2021 | GRANT_AWARD | GENOCEA BIOSCIENCES, INC. | 600,000 | 0.00 USD | deriv |
| 17 Feb 2021 | EXERCISE | GENOCEA BIOSCIENCES, INC. | 19,998 | 2.72 USD | |
| 17 Feb 2021 | EXERCISE | GENOCEA BIOSCIENCES, INC. | 16,500 | 1.66 USD | |
| 17 Feb 2021 | EXERCISE | GENOCEA BIOSCIENCES, INC. | 16,500 | 0.00 USD | deriv |
| 17 Feb 2021 | EXERCISE | GENOCEA BIOSCIENCES, INC. | 19,998 | 0.00 USD | deriv |
| 10 Nov 2020 | PURCHASE | GENOCEA BIOSCIENCES, INC. | 4,760 | 2.06 USD | first after silence |
| 01 Jun 2020 | GRANT_AWARD | GENOCEA BIOSCIENCES, INC. | 27,344 | 0.00 USD | |
| 01 Jun 2020 | GRANT_AWARD | GENOCEA BIOSCIENCES, INC. | 106,688 | 0.00 USD | deriv |
| 02 Apr 2020 | GRANT_AWARD | GENOCEA BIOSCIENCES, INC. | 50,783 | 0.00 USD |
4 purchases reported after at least 12 months of silence — most recent on 10 Jan 2025.